Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px

News > All

Total search results: 6371 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
NLC Ventures Netherlands B.V.. (6/3/24). "Press Release: Dutch Health Insurer VGZ Invests €6 Million in NLC Health Ventures". 2024-06-03
Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. 2024-06-03
SolasCure Ltd.. (6/3/24). "Press Release: SolasCure Selected for Innovate UK Global Incubator Programme in Houston". Cambridge. 2024-06-03
Nyxoah S.A.. (5/31/24). "Press Release: Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares". Mont-Saint-Guibert. 2024-05-31
High-Tech Gründerfonds Management GmbH. (5/30/24). "Press Release: Unlocking Soil Carbon. Berlin-based Climate Tech Startup Seqana Raises €2.1M Seed Round to Unlock Scalable Carbon Farming on 6 Continents from Space". Berlin. 2024-05-30
Adaptimmune Therapeutics plc. (5/30/24). "Press Release: Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future 2024-05-30
BlueRock Therapeutics LP. (5/30/23). "Press Release: BlueRock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Cell Therapy Candidate Bemdaneprocel". Berlin & Cambridge, MA. 2024-05-30
Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg. 2024-05-30
Cellular Origins Ltd.. (5/29/24). "Press Release: Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing". Cambridge & Stevenage. 2024-05-29
Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". 2024-05-29
Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY. 2024-05-29
BRAIN Biotech AG. (5/29/24). "Press Release: BRAIN Biotech AG Announces the Appointment of Erik de Vries as Senior Business Development Director Enzymes". Zwingenberg & Greifswald. 2024-05-29
Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. 2024-05-29
ProBioGen AG. (5/29/24). "Press Release: ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development". Berlin. 2024-05-29
BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. 2024-05-29
Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. 2024-05-29
ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. 2024-05-29
TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund ". Riyadh. 2024-05-28
CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA. 2024-05-28
Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". 2024-05-28
Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H 2024-05-28
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. 2024-05-28
Spectrum.Life. (5/27/24). "Press Release: Spectrum.Life Closes €17M Investment Round to Accelerate International Growth". London. 2024-05-27
Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo. 2024-05-27
Eisbach Bio GmbH. (5/24/24). "Press Release: Eisbach Bio Announces Successful Completion of Phase I Clinical Trial of Nucleic Acid Helicase Inhibitor EIS-10700 with Excellent Safety Properties". Martinsried. 2024-05-24
Radar Therapeutics Inc.. (5/23/24). "Press Release: Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors". Berkeley, CA. 2024-05-23
Orna Therapeutics, Inc.. (5/23/24). "Press Release: Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies". Watertown, MA & Cambridge, MA. 2024-05-23
SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. 2024-05-22
Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris. 2024-05-22
Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes. 2024-05-22
Captain T Cell GmbH. (5/22/24). "Press Release: Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million". Schönefeld/Berlin. 2024-05-22
Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". 2024-05-22
En Carta Diaganostics. (5/22/24). "Press Release: En Carta Diagnostics Secures €1.5m in Pre-seed Funding to Advance Diagnostic Kit Platform for Lyme disease". Paris. 2024-05-22
Deepull Diagnostics S.L.. (5/22/24). "Press Release: Deepull Appoints Didier Deltort to Its Board of Directors". Barcelona. 2024-05-22
BioNTech SE. (5/22/24). "Press Release: BioNTech to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas". Mainz & Göttingen. 2024-05-22
Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford. 2024-05-22
Merck KGaA. (5/22/24). "Press Release: Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million". Darmstadt. 2024-05-22
Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA. 2024-05-22
Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. 2024-05-21
LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London. 2024-05-21
Pheon Therapeutics Ltd.. (5/21/24). "Press Release: Pheon Therapeutics Announces $120m Series B Financing to Fund Development of Its Differentiated ADC Pipeline". London. 2024-05-21
Forbion Capital Partners. (5/21/24). "Press Release: Forbion Leads $65 Million Series A Financing of Progentos Therapeutics". Naarden. 2024-05-21
Limula SA. (5/21/24). "Press Release: Limula Raises CHF 6.2 Million in Oversubscribed Seed Round to Develop Automated Cell and Gene Therapy Manufacturing Platform". Lausanne. 2024-05-21
Ygion Biomedical GmbH. (5/21/24). "Press Release: Ygion Biomedical Announces €15 Million Series A Financing to Develop Individualized Cancer Immunotherapies". 2024-05-21
Cutiss AG. (5/17/24). "Press Release: Cutiss Announces First Closing of CHF 25M in Series C Funding Round". Switzerland. 2024-05-17
Hephaistos-Pharma SAS. (5/16/24). "Press Release: Hephaistos Secures €10.3 M to Reach the Clinical Stage". France. 2024-05-16
Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen. 2024-05-16
Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen. 2024-05-16
Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. 2024-05-15
Cell and Gene Therapy Catapult, The. (5/15/24). "Press Release: UK and Swiss Consortium to Apply Innovative Technologies to Lower Cost of Manufacturing Cell and Gene Therapies". London & Zurich. 2024-05-15
Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg. 2024-05-15
NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried. 2024-05-14
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. 2024-05-13
Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen. 2024-05-13
ERS Genomics Ltd.. (5/13/24). "Press Release: ERS Genomics Appoints John E Milad as Chief Executive Officer". Stockholm. 2024-05-13
Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris. 2024-05-13
AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. 2024-05-13
H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". 2024-05-13
iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies. 2024-05-10
Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. 2024-05-09
Bar-Ilan University. (5/7/24). "Press Release: Opmed.ai Raises $15M". 2024-05-07
BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel. 2024-05-07
Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. 2024-05-07
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. 2024-05-07
Atopia Therapeutics SA. (5/7/24). "Press Release: Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update". Geneva. 2024-05-07
CMR Surgical Ltd.. (5/7/24). "Press Release: CMR Surgical Appoints Shlomi Cohen as Chief Financial Officer". Cambridge. 2024-05-07
Neurocare Group AG. (5/7/24). "Press Release: Neurocare Group AG Appoints Tariq El-Titi as Senior Vice President MENA, Strengthening Commitment to Middle East Health Sector". Dubai & Munich. 2024-05-07
Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. 2024-05-06
ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne. 2024-05-06
Medios AG. (5/6/24). "Press Release: Medios AG – Constantijn van Rietschoten Appointed Executive Board Member for International Markets". Berlin. 2024-05-06
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. (5/6/24). "Press Release: Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies". Beijing. 2024-05-06
Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried. 2024-05-06
Topas Therapeutics GmbH. (5/6/24). "Press Release: Topas Therapeutics Appoints Hugo Fry as CEO". Hamburg. 2024-05-06
WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA. 2024-05-06
Mariana Oncology Inc.. (5/2/24). "Press Release: Mariana Oncology to Be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer". Watertown, MA. 2024-05-02
Kurma Partners. (5/2/24). "Press Release: Kurma Partners Announces the Promotion of Hadrien Bouchez to the Position of Partner". Paris. 2024-05-02
Novartis AG. (5/2/24). "Press Release: Novartis Enters Agreement to Acquire Mariana Oncology, Strengthening Radioligand Therapy Pipeline". Basel. 2024-05-02
Remepy. (5/1/24). "Press Release: Remepy Launches with $15 Million in Funding to Bring First Hybrid Drug To Market". New York, NY. 2024-05-01
ProBioGen AG. (4/30/24). "Press Release: Change in Management". Berlin. 2024-04-30
Avacta Group plc. (4/30/24). "Press Release: Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group". 2024-04-30
Evotec SE. (4/30/24). "Press Release: Bayer and Evotec Collaborate to Advance Precision Cardiology". Berlin & Hamburg. 2024-04-30
PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa. 2024-04-30
Sphere Fluidics Ltd.. (4/30/24). "Press Release: Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer". Cambridge. 2024-04-30
Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. 2024-04-29
General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. 2024-04-29
Locate Bio Ltd.. (4/29/24). "Press Release: Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion". Nottingham. 2024-04-29
Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. 2024-04-29
Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY. 2024-04-26
Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil". 2024-04-26
Variantyx, Inc.. (4/26/24). "Press Release: Variantyx Secures $36M Investment as Testing Demand and Market Share Continues to Increase". Framingham, MA. 2024-04-26
Deepull Diagnostics S.L.. (4/25/24). "Press Release: Deepull Unveils 1 Hour, Direct-from-Blood Multiplex PCR Test for 95% of Sepsis-causing Pathogens at ESCMID 2024". Barcelona. 2024-04-25
Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt. 2024-04-25
CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. 2024-04-24
Seamless Therapeutics GmbH. (4/23/24). "Press Release: Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform". Dresden & Lexington, MA. 2024-04-23
Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg. 2024-04-23
High-Tech Gründerfonds Management GmbH. (4/23/24). "Press Release: Cultimate Foods Raises 2.3 Million EUR Seed Funding from Leading Biotech and Foodtech Investors to Revolutionize the Alternative Meat Industry". Berlin. 2024-04-23
Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. 2024-04-22
Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg. 2024-04-22
Noscendo GmbH. (4/22/24). "Press Release: Labor Dr. Wisplinghoff Partners with Noscendo – NGS-based Pathogen Diagnostics now an Established Part of Their Service Portfolio". 2024-04-22
Outrun Therapeutics Ltd.. (4/18/24). "Press Release: Outrun Therapeutics Launches with a $10m Seed Financing from M Ventures and MP Healthcare Venture Management to Develop a Protein Stabilisation Pipeline". Dundee. 2024-04-18
next pagenext page 1 2 3 ... 62 63 64  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top